Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Diltiazem. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CACNA1S known ✓ | Q13698 | 11/20 | 1.00 |
| ▸ | CACNA1F known ✓ | O60840 | 1/20 | 1.00 |
| ▸ | CACNA1D known ✓ | Q01668 | 1/20 | 1.00 |
| ▸ | CACNA1C known ✓ | Q13936 | 1/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 3/20 | 1.00 |
| ▸ | TSHR | P16473 | 2/20 | 1.00 |
| ▸ | ABCB11 | O95342 | 2/20 | 1.00 |
| ▸ | LMNA | P02545 | 2/20 | 1.00 |
| ▸ | KCNH2 | Q12809 | 2/20 | 1.00 |
| ▸ | SLC22A1 | O15245 | 1/20 | 1.00 |
| ▸ | ABCB1 | P08183 | 1/20 | 1.00 |
| ▸ | HRH2 | P25021 | 1/20 | 1.00 |
| ▸ | ADRA1A | P35348 | 1/20 | 1.00 |
| ▸ | SCN1A | P35498 | 1/20 | 1.00 |
| ▸ | SCN4A | P35499 | 1/20 | 1.00 |
| ▸ | HTT | P42858 | 1/20 | 1.00 |
| ▸ | SCN7A | Q01118 | 1/20 | 1.00 |
| ▸ | PLAUR | Q03405 | 1/20 | 1.00 |
| ▸ | SCN5A | Q14524 | 1/20 | 1.00 |
| ▸ | SCN9A | Q15858 | 1/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Diltiazem SCHEMBL3468378 | 1.00 | CACNA1S (1.00) | CACNA1SCYP3A4TSHRABCB11LMNA | |
| Diltiazem SCHEMBL29353951 | 1.00 | CACNA1S (1.00) | CACNA1SCYP3A4TSHRABCB11LMNA | |
| Diltiazem SCHEMBL17776 | 1.00 | CACNA1S (1.00) | CACNA1SCYP3A4TSHRABCB11LMNA | |
| Diltiazem SCHEMBL30127237 | 1.00 | CACNA1S (1.00) | CACNA1SCYP3A4TSHRABCB11LMNA | |
| Diltiazem SCHEMBL676914 | 1.00 | CACNA1S (1.00) | CACNA1SCYP3A4TSHRABCB11LMNA | |
| Diltiazem SCHEMBL4886734 | 1.00 | CACNA1S (1.00) | CACNA1SCYP3A4TSHRABCB11LMNA | |
| Diltiazem SCHEMBL13575826 | 1.00 | CACNA1S (1.00) | CACNA1SCYP3A4TSHRABCB11LMNA | |
| Diltiazem SCHEMBL30127157 | 1.00 | CACNA1S (1.00) | CACNA1SCYP3A4TSHRABCB11LMNA | |
| Diltiazem SCHEMBL10831293 | 0.99 | CYP3A4 (1.00) | CACNA1SCYP3A4TSHRABCB11LMNA | |
| Diltiazem SCHEMBL8545465 | 0.99 | CYP3A4 (1.00) | CACNA1SCYP3A4TSHRABCB11LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 309 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2010078258-A1 | COMPOUNDS COMPRISING TWO OR MORE BIOLOGICALLY FUNCTIONAL IONS AND METHOD OF TREATING PARKINSON'S DISEASE | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ALABAMA (US) | 2010-07-08 | — | — | WO | claimed |
| EP-1087953-B1 | NITRATE SALTS OF ANTIHYPERTENSIVE MEDICINES | NICOX SA (FR) | 2004-11-17 | — | — | EP | claimed |
| EP-0702009-B1 | Method for the preparation of pharmaceutically active benzothiazepine derivatives | ORION CORP FERMION (FI) | 1998-07-01 | — | — | EP | claimed |
| US-5663332-A | Method for the preparation of 3-hydroxy-5-[2-(dimethylamino)ethyl]-2,3-dihydro-2-(4-methoxy-phenyl)-1,5-benzothiazepine-4(5H)-one | ORION CORPORATION FERMION (FI) | 1997-09-02 | — | — | US | claimed |
| EP-0702009-A1 | Method for the preparation of 3-hydroxy-5-(2-(dimethylamino)-ethy1)-2,3-dihydro-4-(methoxyphenyl)-1,5-benzothiazepin-4(5H)-one and use of the product for making pharmaceutically active compounds | Orion Corporation Fermion (FI) | 1996-03-20 | — | — | EP | claimed |
| US-5407828-A | Hydrolysis; separation of non-hydrolyzed enantiomorph | DSM N.V. (NL) | 1995-04-18 | — | — | US | claimed |
| EP-0561861-B1 | A PROCESS FOR THE PREPARATION OF DILTIAZEM | LUSOCHIMICA SPA (IT) | 1995-03-22 | — | — | EP | claimed |
| EP-0488210-B1 | Process for preparing 1,5-benzothiazepine derivative | TANABE SEIYAKU CO (JP) | 1994-06-22 | — | — | EP | claimed |
| EP-0279425-B1 | USE OF BENZOTHIAZEPINE DERIVATIVES, IN PARTICULAR DILTIAZEM, IN THE MANUFACTURE OF MEDICAMENTS TO PROTECT LYMPHOCYTES | GÖDECKE AKTIENGESELLSCHAFT (DE) | 1993-08-04 | — | — | EP | claimed |
| EP-0488210-A1 | Process for preparing 1,5-benzothiazepine derivative | TANABE SEIYAKU CO., LTD. (JP) | 1992-06-03 | — | — | EP | claimed |
| EP-0430036-A2 | Benzothiazepine metastasis treatment | MARION MERRELL DOW INC. (US) | 1991-06-05 | — | — | EP | claimed |
| EP-0343714-A1 | Phenylglycidate stereoisomers, conversion products thereof with e.g. 2-nitrothiophenol and preparation of diltiazem | DSM N.V. (NL) | 1989-11-29 | — | — | EP | claimed |
| US-4618598-A | Method of regulating hormone function or release | DUKE UNIVERSITY (US) | 1986-10-21 | — | — | US | claimed |
| US-4218466-A | Method of treating gastric and duodenal ulcers | SYNTHELABO (FR) | 1980-08-19 | — | — | US | claimed |
| JP-3170433-A | — | — | None | — | — | JP | disclosed |
| JP-59020221-A | — | — | None | — | — | JP | disclosed |
| JP-61165378-A | — | — | None | — | — | JP | disclosed |
| EP-0059335-A1 | Novel process for preparing threo-2-hydroxy-3-(4-methoxyphenyl)-3-(2-nitrophenylthio)-propionic ester | Tanabe Seiyaku Co., Ltd. (JP) | 1982-09-08 | — | — | EP | disclosed |
| US-4218466-A | Method of treating gastric and duodenal ulcers | SYNTHELABO (FR) | 1980-08-19 | — | — | US | disclosed |
| US-4218466-A | Method of treating gastric and duodenal ulcers | SYNTHELABO (FR) | 1980-08-19 | — | — | US | disclosed |